TRIP4 transcriptionally activates DDIT4 and subsequent mTOR signaling to promote glioma progression
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
TRIP4 transcriptionally activates DDIT4 and subsequent mTOR signaling to promote glioma progression
Authors
Keywords
TRIP4, Glioma, DDIT4, mTOR
Journal
FREE RADICAL BIOLOGY AND MEDICINE
Volume 177, Issue -, Pages 31-47
Publisher
Elsevier BV
Online
2021-10-12
DOI
10.1016/j.freeradbiomed.2021.10.009
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Key Role of DNA Damage-Inducible Transcript 4 (DDIT4) Connects Autophagy and GLUT3-Mediated Stemness To Desensitize Temozolomide Efficacy in Glioblastomas
- (2020) Kuo-Hao Ho et al. Neurotherapeutics
- Tumor antigens in glioma
- (2020) Takahide Nejo et al. SEMINARS IN IMMUNOLOGY
- MicroRNA-518-3p suppresses cell proliferation, invasion and migration in colorectal cancer via targeting TRIP4
- (2020) Heng Yang et al. Biochemistry and Cell Biology
- DDIT4 licenses only healthy cells to proliferate during injury-induced metaplasia
- (2020) Zhi-Feng Miao et al. GASTROENTEROLOGY
- Investigating Glioblastoma Response to Hypoxia
- (2020) Agathe L. Chédeville et al. Biomedicines
- The physiological mTOR complex 1 inhibitor DDIT4 mediates therapy resistance in glioblastoma
- (2019) Martha Foltyn et al. BRITISH JOURNAL OF CANCER
- TRIP4 promotes tumor growth and metastasis and regulates radiosensitivity of cervical cancer by activating MAPK, PI3K/AKT, and hTERT signaling
- (2019) Yilin Che et al. CANCER LETTERS
- A novel rapamycin analog is highly selective for mTORC1 in vivo
- (2019) Katherine H. Schreiber et al. Nature Communications
- Migration/Invasion of Malignant Gliomas and Implications for Therapeutic Treatment
- (2018) Ching-Ann Liu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Tumor-Promoting Role of TRIP4 in Melanoma Progression and its Involvement in Response to BRAF-Targeted Therapy
- (2018) Jiaojiao Hao et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- DNA Damage Inducible Transcript 4 Gene: The Switch of the Metabolism as Potential Target in Cancer
- (2018) Indira Tirado-Hurtado et al. Frontiers in Oncology
- Novel ASCC1 mutations causing prenatal-onset muscle weakness with arthrogryposis and congenital bone fractures
- (2018) Johann Böhm et al. JOURNAL OF MEDICAL GENETICS
- An Anti-Cancer Drug Candidate OSI-027 and its Analog as Inhibitors of mTOR: Computational Insights Into the Inhibitory Mechanisms
- (2017) Mohd Rehan JOURNAL OF CELLULAR BIOCHEMISTRY
- Synergy between Androgen Receptor Antagonism and Inhibition of mTOR and HER2 in Breast Cancer
- (2017) Michael A. Gordon et al. MOLECULAR CANCER THERAPEUTICS
- The contribution of tumor-associated macrophages in glioma neo-angiogenesis and implications for anti-angiogenic strategies
- (2017) Changbin Zhu et al. NEURO-ONCOLOGY
- In silico evaluation of DNA Damage Inducible Transcript 4 gene (DDIT4) as prognostic biomarker in several malignancies
- (2017) Joseph A. Pinto et al. Scientific Reports
- Mutations in Subunits of the Activating Signal Cointegrator 1 Complex Are Associated with Prenatal Spinal Muscular Atrophy and Congenital Bone Fractures
- (2016) Ellen Knierim et al. AMERICAN JOURNAL OF HUMAN GENETICS
- REDD1/DDIT4-Independent mTORC1 Inhibition and Apoptosis by Glucocorticoids in Thymocytes
- (2014) Nicholas C. Wolff et al. MOLECULAR CANCER RESEARCH
- Modification of ASC1 by UFM1 Is Crucial for ERα Transactivation and Breast Cancer Development
- (2014) Hee Min Yoo et al. MOLECULAR CELL
- CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007-2011
- (2014) Q. T. Ostrom et al. NEURO-ONCOLOGY
- The epidemiology of glioma in adults: a "state of the science" review
- (2014) Q. T. Ostrom et al. NEURO-ONCOLOGY
- REDD1 is required for RAS-mediated transformation of human ovarian epithelial cells
- (2011) Bin Chang et al. CELL CYCLE
- REDD1, a new Ras oncogenic effector
- (2011) Elizabeth R. Smith et al. CELL CYCLE
- Rapamycin passes the torch: a new generation of mTOR inhibitors
- (2011) Don Benjamin et al. NATURE REVIEWS DRUG DISCOVERY
- Multi-mechanisms are involved in reactive oxygen species regulation of mTORC1 signaling
- (2010) Ming Li et al. CELLULAR SIGNALLING
- Hydrogen peroxide impairs insulin-stimulated assembly of mTORC1
- (2009) Lianqin Zhang et al. FREE RADICAL BIOLOGY AND MEDICINE
- Hypoxia regulates TSC1/2 mTOR signaling and tumor suppression through REDD1-mediated 14 3 3 shuttling
- (2008) M. P. DeYoung et al. GENES & DEVELOPMENT
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now